Kesler, Norman & Wride, LLC Eli Lilly & CO Transaction History
Kesler, Norman & Wride, LLC
- $501 Million
- Q1 2025
A detailed history of Kesler, Norman & Wride, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kesler, Norman & Wride, LLC holds 5,257 shares of LLY stock, worth $4.18 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
5,257
Previous 4,774
10.12%
Holding current value
$4.18 Million
Previous $3.69 Million
17.8%
% of portfolio
0.87%
Previous 0.83%
Shares
6 transactions
Others Institutions Holding LLY
# of Institutions
4,395Shares Held
821MCall Options Held
10MPut Options Held
10.8M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$80.6 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$76.3 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$63 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$52.4 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$27.4 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $756B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...